AnteoTech Ltd (AU:ADO)
ASX:ADO
Want to see AU:ADO full AI Analyst Report?
ADO Stock Chart & Stats
AU$0.02
>-AU$0.01(-5.00%)
At close: 4:00 PM EST
AU$0.02
>-AU$0.01(-5.00%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.03
Previous CloseN/A
Volume1.67M
Average Volume (3M)1.47M
Market Cap
AU$38.65M
Enterprise ValueAU$40.06M
Total Cash (Recent Filing)AU$1.44M
Total Debt (Recent Filing)AU$2.85M
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,973,138,700
10 Day Avg. Volume1,501,441
30 Day Avg. Volume1,471,917
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)10.79
Price to Sales (P/S)35.07
P/FCF Ratio-5.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.01
Revenue Forecast (FY)AU$1.70M
Bulls Say, Bears Say
Bulls Say
Proprietary IP And Diversified CommercializationAnteoTech’s core proprietary surface‑functionalisation technology underpins multiple revenue pathways (product sales, licensing, paid development, grants). This IP-driven, partner-centric model supports recurring royalties and product embedding, enabling durable scaling as partners validate and commercialise.
Exposure To Durable End MarketsThe company’s technology addresses structural growth markets — diagnostics/biosensors and advanced batteries — that have multi-year secular demand. Cross-sector applicability creates optionality to win in higher-volume diagnostics consumables and battery manufacturing applications as those industries expand.
Manageable Leverage On Balance SheetA moderate debt-to-equity ratio (0.62) provides financial flexibility and reduces immediate solvency risk versus highly leveraged peers. Manageable leverage helps preserve access to capital and supports continued R&D and commercialisation efforts while the business works toward sustainable cash generation.
Bears Say
Persistent Negative ProfitabilityThe company consistently reports negative operating and profitability margins, indicating it is not yet translating gross margin strength into operating profits. Prolonged unprofitability erodes reserves, increases reliance on external funding, and limits reinvestment capacity for commercialization.
Negative Operating And Free Cash FlowSustained negative operating and free cash flow create structural funding pressure, forcing dependence on capital raises or debt. This constrains long‑term investment in scale-up, customer qualification and manufacturing, and raises dilution or refinancing risk that can impede durable commercial progress.
Severe Revenue Volatility And Recent Steep DeclinesHighly volatile revenues and sharp recent declines undermine predictable scaling and make forecasting partner uptake difficult. Lumpy top-line performance harms margins and complicates commercialization timelines, increasing execution risk for converting IP and partnerships into steady, repeatable revenue.
AnteoTech Ltd News
ADO FAQ
What was AnteoTech Ltd’s price range in the past 12 months?
AnteoTech Ltd lowest share price was <AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is AnteoTech Ltd’s market cap?
AnteoTech Ltd’s market cap is AU$38.65M.
When is AnteoTech Ltd’s upcoming earnings report date?
AnteoTech Ltd’s upcoming earnings report date is Sep 01, 2026 which is in 113 days.
How were AnteoTech Ltd’s earnings last quarter?
AnteoTech Ltd released its earnings results on Feb 24, 2026. The company reported AU$0 earnings per share for the quarter, the consensus estimate of N/A by AU$0.
Is AnteoTech Ltd overvalued?
According to Wall Street analysts AnteoTech Ltd’s price is currently Overvalued.
Does AnteoTech Ltd pay dividends?
AnteoTech Ltd does not currently pay dividends.
What is AnteoTech Ltd’s EPS estimate?
AnteoTech Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AnteoTech Ltd have?
AnteoTech Ltd has 2,973,138,700 shares outstanding.
What happened to AnteoTech Ltd’s price movement after its last earnings report?
AnteoTech Ltd reported an EPS of AU$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of AnteoTech Ltd?
Currently, no hedge funds are holding shares in AU:ADO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AnteoTech Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ADO Sentiment 98%
Sector Average 72%
Sector Average 72%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.00%
12-Months-Change
Fundamentals
Return on Equity
-142.30%
Trailing 12-Months
Asset Growth
-58.00%
Trailing 12-Months
Company Description
AnteoTech Ltd
AnteoTech Limited, a surface chemistry company, develops, commercializes, manufactures, and distributes products for the life sciences, diagnostics, energy, and medical device markets primarily in Australia. Its products include AnteoBind ready-to-use kits to streamline and enhance the conjugation process; AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes; EuGeni, a COVID-19 antigen rapid test; and AnteoRelease and AnteoCoat. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
Technical Analysis
Cynata Therapeutics Limited
―
Prescient Therapeutics Limited
―
Starpharma Holdings Limited
―
Avecho Biotechnology Limited
―
Proteomics International Laboratories Ltd.
―